FdaApplication
BLA 761125
Identifiers
- fda_app_no: BLA761125
Properties
| Property | Value |
|---|---|
| applicant_name | Novartis Pharmaceuticals Corporation |
| application_type | BLA |
| approval_date | 2019-10-07 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BEOVU | brolucizumab-dbll | 6MG/0.05ML | INJECTABLE;INTRAVITREAL |
| BEOVU | — | 6MG/0.05ML | Injection |
2 products